Evidence map›Paper›PMID 26607280›Full record

ArticleScientific reports2015

Fibulin-4 deficiency increases TGF-β signalling in aortic smooth muscle cells due to elevated TGF-β2 levels.

N W M Ramnath, L J A C Hawinkels, P M van Heijningen, L te Riet, M Paauwe, M Vermeij, A H J Danser, R Kanaar, P ten Dijke, J Essers

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Elastic Fibre Proteins in Elastogenesis and Wound Healing.International journal of molecular sciences · 2022
    Review
  9. Review
  10. Review
  11. Article
  12. Modulating smooth muscle cell response by the release of TGFβ2 from tubular scaffolds for vascular tissue engineering.Journal of controlled release : official journal of the Controlled Release Society · 2019
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

N W M RamnathDepartment of Genetics, Cancer Genomics Centre Netherlands, Erasmus MC, Rotterdam, The Netherlands.
L J A C HawinkelsDepartment of Molecular Cell Biology Leiden University Medical Centre, Leiden, The Netherlands, Cancer Genomics Centre.
P M van HeijningenDepartment of Genetics, Cancer Genomics Centre Netherlands, Erasmus MC, Rotterdam, The Netherlands.
L te RietDepartment of Vascular Surgery, Erasmus MC, Rotterdam, The Netherlands.
M PaauweDepartment of Molecular Cell Biology Leiden University Medical Centre, Leiden, The Netherlands, Cancer Genomics Centre.
M VermeijDepartment of Pathology, Erasmus MC, Rotterdam, The Netherlands.
A H J DanserDepartment of Pharmacology, Erasmus MC, Rotterdam, The Netherlands.
R KanaarDepartment of Genetics, Cancer Genomics Centre Netherlands, Erasmus MC, Rotterdam, The Netherlands.
P ten DijkeDepartment of Molecular Cell Biology Leiden University Medical Centre, Leiden, The Netherlands, Cancer Genomics Centre.
J EssersDepartment of Genetics, Cancer Genomics Centre Netherlands, Erasmus MC, Rotterdam, The Netherlands.
Erasmus MC · NLCancer Genomics Centre · NLErasmus University Rotterdam · NLLeiden University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fibulins are extracellular matrix proteins associated with elastic fibres. Homozygous Fibulin-4 mutations lead to life-threatening abnormalities such as aortic aneurysms. Aortic aneurysms in Fibulin-4 mutant mice were associated with upregulation of TGF-β signalling. How Fibulin-4 deficiency leads to deregulation of the TGF-β pathway is largely unknown. Isolated aortic smooth muscle cells (SMCs) from Fibulin-4 deficient mice showed reduced growth, which could be reversed by treatment with TGF-β neutralizing antibodies. In Fibulin-4 deficient SMCs increased TGF-β signalling was detected using a transcriptional reporter assay and by increased SMAD2 phosphorylation. Next, we investigated if the increased activity was due to increased levels of the three TGF-β isoforms. These data revealed slightly increased TGF-β1 and markedly increased TGF-β2 levels. Significantly increased TGF-β2 levels were also detectable in plasma from homozygous Fibulin-4(R/R) mice, not in wild type mice. TGF-β2 levels were reduced after losartan treatment, an angiotensin-II type-1 receptor blocker, known to prevent aortic aneurysm formation. In conclusion, we have shown increased TGF-β signalling in isolated SMCs from Fibulin-4 deficient mouse aortas, not only caused by increased levels of TGF-β1, but especially TGF-β2. These data provide new insights in the molecular interaction between Fibulin-4 and TGF-β pathway regulation in the pathogenesis of aortic aneurysms.

Indexed as

Signal TransductionAnimalsAortaAorta, ThoracicCell ProliferationExtracellular Matrix ProteinsHumansHuman Umbilical Vein Endothelial CellsMice, Inbred C57BLMyocytes, Smooth MuscleReal-Time Polymerase Chain ReactionTransforming Growth Factor beta1Transforming Growth Factor beta2EFEMP2 protein, humanExtracellular Matrix ProteinsTransforming Growth Factor beta1Transforming Growth Factor beta2

Identifiers

PMID26607280
PMCPMC4660353
OpenAlexW2405919465

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.